Opportunity Information: Apply for CDC RFA GH11 11090501SUPP16
Apply for CDC RFA GH11 11090501SUPP16
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Program Expansion Supplement: Strengthening Local Capacity to Provide Sustainable HIV-Related Care and Treatment Services in South Africa" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Aug 02, 2016.
- Applicants must submit their applications by Oct 01, 2016 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $15,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The "Program Expansion Supplement: Strengthening Local Capacity to Provide Sustainable HIV-Related Care and Treatment Services in South Africa" is a CDC cooperative agreement funding opportunity under PEPFAR that is meant to deepen and extend U.S. technical support for South Africa's national HIV response. It sits within the broader PEPFAR model where CDC, working under the U.S. Global AIDS Coordinator, partners with host-country governments to tailor support to national strategies and to strengthen systems that can maintain results long after external funding declines. The overall thrust is not just delivering services, but improving how services are planned, managed, measured, and sustained across community, primary care, and tertiary levels of the health system.
Programmatically, the opportunity emphasizes a full continuum of HIV work. On prevention, it highlights expanding confidential HIV counseling and testing that is actively linked to evidence-based behavior change interventions, alongside efforts to reduce mother-to-child transmission. On treatment and clinical care, it prioritizes improving management of HIV/AIDS, sexually transmitted infections, and opportunistic infections, while also strengthening laboratory diagnostic capacity that supports diagnosis, monitoring, and treatment decisions. It also explicitly calls out the integration of tuberculosis services, reflecting the high burden of HIV/TB co-infection, and supports the initiation and expansion of antiretroviral therapy services. In parallel, the FOA underscores surveillance and data use as core capacities: expanding HIV/STI/TB surveillance, improving laboratory support for surveillance and blood safety screening, and building national and subnational capacity to use data for program management and performance improvement. It also encourages the development, validation, and evaluation of public health programs so that interventions are better targeted and continuously improved based on evidence.
A major theme running through the announcement is coordination and efficiency, aligned with Global Health Initiative principles. Recipients may be asked to participate in efforts that raise impact through integration and partner alignment, including strategic coordination across implementers and with government, stronger engagement with multilateral organizations and public-private partnerships, and steps that reinforce country ownership. The FOA also signals cross-cutting expectations such as taking a woman- and girl-centered approach, investing in health systems to build sustainability, improving metrics and monitoring and evaluation, and promoting innovation and applied learning that can refine service delivery models over time.
In terms of purpose and outcomes, the FOA frames success around PEPFAR's overarching goals in South Africa: reducing HIV- and TB-related morbidity and mortality, preventing new infections, and strengthening the effectiveness of the HIV response system at district, provincial, and national levels. A practical, on-the-ground expectation is that the funded partner will work closely with district Departments of Health and their designees to identify gaps, shape policies and programs, and improve the district-level response for HIV prevention, care, and treatment. This focus on district systems reflects the idea that durable gains depend on how well local management, supervision, and clinical quality function where patients actually receive care.
Operationally, this supplement builds on earlier CDC/PEPFAR investments in HIV clinical services and ART programs, and it is designed to ensure continuity of technical assistance to the South African National Department of Health as services expand to both current and future clients. The FOA specifically indicates funding to Health Systems Trust to continue and expand technical assistance supporting comprehensive HIV prevention, care, and ART scale-up. Key activities described include building the capacity of health personnel through continuous quality improvement approaches, setting and reinforcing standards of care, providing mentorship and training for clinical and ancillary staff, and ensuring day-to-day adherence to South Africa's National Care and Treatment guidelines. The recipient is expected to operate under the direction of provincial and district health authorities and coordinate with the U.S. Government-designated district coordination partner, reinforcing a managed, government-led implementation structure rather than a parallel system.
Geographically, the work may be concentrated in CDC priority districts, with potential district coordination responsibilities in one or more provinces listed in the announcement: Free State, Eastern Cape, KwaZulu-Natal, and North West. This suggests the supplement is meant to intensify support where the epidemic burden is high or where system strengthening can yield outsized improvements in coverage and quality.
From an administrative standpoint, the opportunity is a discretionary cooperative agreement (CFDA 93.067) issued by the HHS Centers for Disease Control and Prevention (CGH). The funding opportunity number is CDC RFA GH11 11090501SUPP16, originally posted August 2, 2016, with an original application deadline of October 1, 2016 (11:59 p.m. ET for electronic submissions). The ceiling listed is $15,000,000, with an expectation of a single award, which matches the narrative indicating targeted continued support through a specific technical partner.
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled "Program Expansion Supplement: Strengthening Local Capacity to Provide Sustainable HIV-Related Care and Treatment Services in South Africa."
Which U.S. agency is offering this opportunity?
This is a discretionary cooperative agreement issued by the HHS Centers for Disease Control and Prevention (CDC), specifically within CDC's Center for Global Health (CGH).
Is this opportunity part of PEPFAR?
Yes. The announcement describes it as a CDC cooperative agreement funding opportunity under PEPFAR, aligned with the broader PEPFAR model of supporting host-country national strategies and long-term sustainability.
What is the main purpose of this supplement?
The purpose is to deepen and extend U.S. technical support for South Africa's national HIV response, with an emphasis on strengthening local systems so results can be maintained as external funding declines.
Is the focus on direct service delivery or systems strengthening?
While the work spans the HIV continuum, the overall thrust is not only delivering services, but improving how services are planned, managed, measured, coordinated, and sustained across community, primary care, and tertiary levels.
What outcomes does the FOA define as success?
The FOA frames success around PEPFAR's overarching goals in South Africa: reducing HIV- and TB-related morbidity and mortality, preventing new infections, and strengthening the effectiveness of the HIV response system at district, provincial, and national levels.
What prevention activities are emphasized?
The prevention emphasis includes expanding confidential HIV counseling and testing that is actively linked to evidence-based behavior change interventions, along with efforts to reduce mother-to-child transmission.
What treatment and clinical care areas are prioritized?
The FOA prioritizes improving management of HIV/AIDS, sexually transmitted infections (STIs), and opportunistic infections, and it supports initiation and expansion of antiretroviral therapy (ART) services.
How does the opportunity address tuberculosis (TB)?
It explicitly calls for integration of tuberculosis services, reflecting the high burden of HIV/TB co-infection, and positions TB integration as part of strengthening the continuum of care.
What laboratory-related work is included?
The opportunity includes strengthening laboratory diagnostic capacity to support diagnosis, monitoring, and treatment decisions, as well as improving laboratory support for surveillance and blood safety screening.
What does the FOA say about surveillance and data use?
Surveillance and data use are described as core capacities. The FOA highlights expanding HIV/STI/TB surveillance and building national and subnational capacity to use data for program management and performance improvement.
Does the announcement include monitoring and evaluation expectations?
Yes. It signals cross-cutting expectations around improving metrics and monitoring and evaluation, along with using data for performance improvement.
Are program development and evaluation part of the work?
Yes. The FOA encourages the development, validation, and evaluation of public health programs so interventions can be better targeted and continuously improved based on evidence.
What does the FOA say about coordination and partner alignment?
Coordination and efficiency are major themes, aligned with Global Health Initiative principles. Recipients may be asked to participate in efforts that increase impact through integration, strategic coordination across implementers and government, engagement with multilateral organizations and public-private partnerships, and reinforcement of country ownership.
What cross-cutting approaches are highlighted?
The FOA highlights a woman- and girl-centered approach, investment in health systems for sustainability, stronger metrics and monitoring and evaluation, and promoting innovation and applied learning to refine service delivery models over time.
What is expected at the district level?
A practical expectation is that the funded partner will work closely with district Departments of Health and their designees to identify gaps, shape policies and programs, and improve the district-level response for HIV prevention, care, and treatment.
How does this supplement relate to prior CDC/PEPFAR investments?
The supplement builds on earlier CDC/PEPFAR investments in HIV clinical services and ART programs and is designed to ensure continuity of technical assistance to South Africa's National Department of Health as services expand to current and future clients.
Which organization is indicated to receive funding in the announcement narrative?
The FOA specifically indicates funding to Health Systems Trust to continue and expand technical assistance supporting comprehensive HIV prevention, care, and ART scale-up.
What types of capacity-building activities are described?
Key activities include building the capacity of health personnel through continuous quality improvement approaches, setting and reinforcing standards of care, providing mentorship and training for clinical and ancillary staff, and supporting day-to-day adherence to South Africa's National Care and Treatment guidelines.
Who directs or oversees the recipient's work on the ground?
The recipient is expected to operate under the direction of provincial and district health authorities and coordinate with the U.S. Government-designated district coordination partner, reflecting a government-led implementation structure.
Where in South Africa may the work be concentrated?
The work may be concentrated in CDC priority districts, with potential district coordination responsibilities in one or more of the provinces listed in the announcement: Free State, Eastern Cape, KwaZulu-Natal, and North West.
What is the assistance mechanism type?
The opportunity is a discretionary cooperative agreement.
What is the CFDA number for this opportunity?
The CFDA number listed is 93.067.
What is the funding opportunity number?
The funding opportunity number is CDC RFA GH11 11090501SUPP16.
When was the opportunity originally posted?
The announcement states it was originally posted on August 2, 2016.
What was the original application deadline?
The original application deadline was October 1, 2016, with electronic submissions due by 11:59 p.m. ET.
What is the maximum funding amount (ceiling) listed?
The ceiling listed in the announcement is $15,000,000.
How many awards does the FOA expect to make?
The FOA indicates an expectation of a single award, consistent with the narrative describing targeted continued support through a specific technical partner.
Browse more opportunities from the same category: Health
Next opportunity: L16AS00135 BLM-NOC West-wide Wetland and Riparian Mapping Assessment
Previous opportunity: FY2017 Young Transatlantic Innovation Leaders Initiative Fellowship
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 11090501SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 11090501SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Program Expansion Supplement: Technical Assistance Services to Countries Supported by the President's Emergency Plan for HIV/AIDS Relief (PEPFAR) and the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Apply for CDC RFA GH13 13680302SUPP16 Funding Number: CDC RFA GH13 13680302SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $900,000 |
| National Hemophilia Program Coordinating Center Apply for HRSA 17 087 Funding Number: HRSA 17 087 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improvement of Laboratory and Clinical Services, and Collaboration across the National HIV and TB Programs in Vietnam under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1711 Funding Number: CDC RFA GH17 1711 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Regional Hemophilia Network Apply for HRSA 17 074 Funding Number: HRSA 17 074 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Polio Eradication and Emergency Response in Priority Countries Apply for CDC RFA GH16 172102CONT17 Funding Number: CDC RFA GH16 172102CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Program Expansion Supplement: Strengthening Local Capacity to Deliver Sustainable Quality-Assured Universal Coverage of Clinical HIV/TB Services and Provide Central Level Technical Assistance in Swaziland Natl AIDS Program under PEPFAR Apply for CDC RFA GH15 15820201SUPP16 Funding Number: CDC RFA GH15 15820201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $355,549 |
| Cooperative Agreement on Immunization with United Nations Children's Fund (UNICEF) Apply for CDC RFA GH13 13020401SUPP16 Funding Number: CDC RFA GH13 13020401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Program Expansion Supplement: Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in SA under PEPFAR Apply for CDC RFA GH11 11540501SUPP16 Funding Number: CDC RFA GH11 11540501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,500,000 |
| Delivering Comprehensive Services to Achieve HIV Epidemic Control in Subnational Units in Nigeria under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1753 Funding Number: CDC RFA GH17 1753 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $200,000,000 |
| Building the Capacity of the Government of Suriname to Address Gaps in the HIV Continuum of Care for Key Populations and People Living with HIV (PLHIV) under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1774 Funding Number: CDC RFA GH17 1774 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $300,000 |
| Program Expansion Supplement for Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in South Africa under PEPFAR Apply for CDC RFA GH11 11520501SUPP16 Funding Number: CDC RFA GH11 11520501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,604,705 |
| Supporting Local Indigenous Faith-Based Partners in Providing High Quality HIV Care, Prevention and Treatment Services and Improving Linkage and Retention in the Republic of Guyana under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1721 Funding Number: CDC RFA GH17 1721 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $465,000 |
| Support for Quality Facility and Community-based Antiretroviral Therapy (ART) for Adults and Children in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1718 Funding Number: CDC RFA GH17 1718 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $10,000,000 |
| Strengthening Care and Support Services for Highly Vulnerable Populations, Orphans and Vulnerable Children and their Families, plus HIV Prevention for Youth in the Republic of Cote d'Ivoire under PEPFAR Apply for CDC RFA GH17 1755 Funding Number: CDC RFA GH17 1755 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $18,000,000 |
| Projecto de Saúde Para Todos (Health for All, or HFA) Apply for NFO RFA 654 16 000004 Funding Number: NFO RFA 654 16 000004 Agency: Agency for International Development, South Africa USAID-Pretoria Category: Health Funding Amount: $63,000,000 |
| Program Expansion Supplement: Scaling up Voluntary Medical Male Circumcision through improvement in HIV prevention under PEPFAR Apply for CDC RFA GH13 13280401SUPP16 Funding Number: CDC RFA GH13 13280401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,000,000 |
| Human Heredity and Health in Africa (H3Africa): Coordinating Center (U24) Apply for RFA RM 16 017 Funding Number: RFA RM 16 017 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $400,000 |
| Human Heredity and Health in Africa (H3Africa): Informatics Network (U24) Apply for RFA RM 16 011 Funding Number: RFA RM 16 011 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Vector Control Strategies- Enhancing Capacity for Vector Surveillance and Control to Prevent Zika, Dengue and Chikungunya Infection in Puerto Rico - Financed in part by Prevention and Public Health Funds Apply for CDC RFA CK16 1608PPHF2016 Funding Number: CDC RFA CK16 1608PPHF2016 Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
| Addressing Ebola and other Highly Infectious Diseases Internationally Apply for CDC RFA CK15 15050104SUPP16 Funding Number: CDC RFA CK15 15050104SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 11090501SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.